ICPT - Intercept Pharmaceuticals Inc
IEX Last Trade
10.65
0.260 2.441%
Share volume: 789,330
Last Updated: Tue 08 Aug 2023 09:59:59 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$10.39
0.26
2.50%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
Report Date | 2022-05-06 | 2022-08-03 | 2022-11-01 | 2023-03-02 | 2023-04-27 | 2023-08-02 | |
Assets | |||||||
Total Assets | 503.357 M | 498.597 M | 559.404 M | 553.711 M | 504.085 M | 484.635 M | |
Current Assets | 477.353 M | 487.015 M | 545.370 M | 540.127 M | 490.457 M | 470.769 M | |
Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Other Current Assets | 24.354 M | 17.307 M | 21.370 M | 22.356 M | 26.497 M | 25.986 M | |
Short Term Investments | 24.354 M | 17.307 M | 21.370 M | 22.356 M | 26.497 M | 25.986 M | |
Total Receivables | 46.144 M | 27.516 M | 26.168 M | 26.862 M | 28.745 M | 29.792 M | |
Current Cash | 395.702 M | 404.776 M | 490.851 M | 485.566 M | 433.595 M | 413.859 M | |
Total Non-current Assets | 26.004 M | 11.582 M | 14.034 M | 13.584 M | 13.628 M | 13.866 M | |
Property Plant Equipment | 3.059 M | 1.002 M | 1.276 M | 987.000 K | 899.000 K | 906.000 K | |
Other Assets | 22.945 M | 10.580 M | 12.758 M | 12.597 M | 12.729 M | 12.960 M | |
Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Liabilities and shareholders’ equity | |||||||
Total Liabilities and shareholders’ equity | 503.357 M | 498.597 M | 559.404 M | 553.711 M | 504.085 M | 484.635 M | |
Total liabilities | 875.118 M | 868.430 M | 451.728 M | 460.634 M | 436.900 M | 417.089 M | |
Total current liabilities | 151.036 M | 151.427 M | 221.584 M | 230.077 M | 207.117 M | 187.022 M | |
Accounts Payable | 10.386 M | 11.666 M | 21.303 M | 14.234 M | 12.744 M | 85.000 K | |
Other liabilities | 7.197 M | 3.144 M | 7.288 M | 7.453 M | 6.431 M | 6.464 M | |
Current long term debt | 0.000 | 0.000 | 109.452 M | 109.569 M | 109.688 M | 109.808 M | |
Long term debt | 716.885 M | 713.859 M | 222.856 M | 223.104 M | 223.352 M | 223.603 M | |
Other liabilities | 7.197 M | 3.144 M | 7.288 M | 7.453 M | 6.431 M | 6.464 M | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | -371.761 M | -369.833 M | 107.676 M | 93.077 M | 67.185 M | 67.546 M | |
Common stock | 29.696 M | 29.747 M | 34.293 M | 41.612 M | 41.670 M | 41.731 M | |
Retained earnings | -2.376 B | -2.384 B | -2.116 B | -2.137 B | -2.169 B | -2.175 B |